Avacta Therapeutics
  • About
  • Our Science
  • Pipeline
  • News
  • Investors
  • Careers
  • Contact
  • About
    • About Avacta
    • Leadership
    • Intellectual Property
  • Our Science
    • Our Science
    • 1st Gen
    • 2nd Gen
    • 3rd Gen
    • Partners
    • Clinical trials
  • Pipeline
  • News
  • Investors
    • Investors
    • Key info
    • Corporate Governance
    • Resources
    • Publications
    • Share price
    • RNS News
    • Events
    • Research
  • Careers
    • Job vacancies
    • Benefits of working at Avacta
  • Contact
  • About
    • About Avacta
    • Leadership
    • Intellectual Property
  • Our Science
    • Our Science
    • 1st Gen
    • 2nd Gen
    • 3rd Gen
    • Partners
    • Clinical trials
  • Pipeline
  • News
  • Investors
    • Investors
    • Key info
    • Corporate Governance
    • Resources
    • Publications
    • Share price
    • RNS News
    • Events
    • Research
  • Careers
    • Job vacancies
    • Benefits of working at Avacta
  • Contact
Home Investors Investor Resources General Meeting Documents

General Meeting Documents

See further information regarding General Meetings below

  • AGM Notice – 2024
  • Notice of General Meeting – March 2024
  • Notice of General Meeting Circular – March 2024
  • AGM 2023 – Business update / Q and A video
  • AGM 2023 – presentation decks
  • Result of AGM RNS – 28 June 2023
  • AGM Notice – June 2023
  • Notice of Annual General Meeting – June 2022
  • Result of Annual General Meeting – 28 June 2021
  • Notice of Annual General Meeting – 28 June 2021
  • Results of Annual General Meeting Proxy Voting Report – 22nd June 2020
  • Notice of General Meeting – 24 June 2020
  • Notice of Annual General Meeting – 22 June 2020
  • Result of General Meeting Proxy Voting Report April 2020
  • Notice of General Meeting – 23 April 2020
  • Circular – April 2020

Avacta Therapeutics
  • Terms of Use
  • Terms & Conditions
  • Privacy Policy
  • Intellectual Property
  • Corporate Responsibility
  • Contact Us

Avacta Group plc

Scale Space,  White City
Imperial College Campus
58 Wood Lane
London
W12 7RZ

+44 (0)20 3911 0353

Investor Enquiries

Cohesion Bureau

 

Email

Twitter | Linkedin

©2026 Avacta Therapeutics. Registered company no. 06605196.